Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 2002 Jun;61(6):479–481. doi: 10.1136/ard.61.6.479

Follow up studies in rheumatoid arthritis

R Landewe, D van der Heijde
PMCID: PMC1754110  PMID: 12006315

Full Text

The Full Text of this article is available as a PDF (84.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Drossaers-Bakker K. W., de Buck M., van Zeben D., Zwinderman A. H., Breedveld F. C., Hazes J. M. Long-term course and outcome of functional capacity in rheumatoid arthritis: the effect of disease activity and radiologic damage over time. Arthritis Rheum. 1999 Sep;42(9):1854–1860. doi: 10.1002/1529-0131(199909)42:9<1854::AID-ANR9>3.0.CO;2-F. [DOI] [PubMed] [Google Scholar]
  2. Felson D. T., Anderson J. J., Boers M., Bombardier C., Furst D., Goldsmith C., Katz L. M., Lightfoot R., Jr, Paulus H., Strand V. American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum. 1995 Jun;38(6):727–735. doi: 10.1002/art.1780380602. [DOI] [PubMed] [Google Scholar]
  3. González-Gay M. A., Blanco R., García-Porrúa C., Ibáez D., Vázquez-Caruncho M., Sánchez-Bursón J., Marenco J. L. Long-term followup of patients receiving combined therapy with cyclosporine and methotrexate. Arthritis Rheum. 1998 Sep;41(9):1703–1704. doi: 10.1002/1529-0131(199809)41:9<1703::AID-ART25>3.0.CO;2-D. [DOI] [PubMed] [Google Scholar]
  4. Heitjan D. F. Causal inference in a clinical trial: a comparative example. Control Clin Trials. 1999 Aug;20(4):309–318. doi: 10.1016/s0197-2456(99)00012-4. [DOI] [PubMed] [Google Scholar]
  5. Jessop J. D., O'Sullivan M. M., Lewis P. A., Williams L. A., Camilleri J. P., Plant M. J., Coles E. C. A long-term five-year randomized controlled trial of hydroxychloroquine, sodium aurothiomalate, auranofin and penicillamine in the treatment of patients with rheumatoid arthritis. Br J Rheumatol. 1998 Sep;37(9):992–1002. doi: 10.1093/rheumatology/37.9.992. [DOI] [PubMed] [Google Scholar]
  6. Landewé R. B., van den Borne B. E., Breedveld F. C., Dijkmans B. A. Does cyclosporin A cause cancer? Nat Med. 1999 Jul;5(7):714–714. doi: 10.1038/10417. [DOI] [PubMed] [Google Scholar]
  7. Landewé Robert B. M., Boers Maarten, Verhoeven Arco C., Westhovens Rene, van de Laar Mart A. F. J., Markusse Harry M., van Denderen J. Christiaan, Westedt Marie Louise, Peeters Andre J., Dijkmans Ben A. C. COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention. Arthritis Rheum. 2002 Feb;46(2):347–356. doi: 10.1002/art.10083. [DOI] [PubMed] [Google Scholar]
  8. Lee Y. J., Ellenberg J. H., Hirtz D. G., Nelson K. B. Analysis of clinical trials by treatment actually received: is it really an option? Stat Med. 1991 Oct;10(10):1595–1605. doi: 10.1002/sim.4780101011. [DOI] [PubMed] [Google Scholar]
  9. Newell D. J. Intention-to-treat analysis: implications for quantitative and qualitative research. Int J Epidemiol. 1992 Oct;21(5):837–841. doi: 10.1093/ije/21.5.837. [DOI] [PubMed] [Google Scholar]
  10. Plant M. J., Williams A. L., O'Sullivan M. M., Lewis P. A., Coles E. C., Jessop J. D. Relationship between time-integrated C-reactive protein levels and radiologic progression in patients with rheumatoid arthritis. Arthritis Rheum. 2000 Jul;43(7):1473–1477. doi: 10.1002/1529-0131(200007)43:7<1473::AID-ANR9>3.0.CO;2-N. [DOI] [PubMed] [Google Scholar]
  11. Sander O., Herborn G., Bock E., Rau R. Prospective six year follow up of patients withdrawn from a randomised study comparing parenteral gold salt and methotrexate. Ann Rheum Dis. 1999 May;58(5):281–287. doi: 10.1136/ard.58.5.281. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Scott D. L., Smolen J. S., Kalden J. R., van de Putte L. B., Larsen A., Kvien T. K., Schattenkirchner M., Nash P., Oed C., Loew-Friedrich I. Treatment of active rheumatoid arthritis with leflunomide: two year follow up of a double blind, placebo controlled trial versus sulfasalazine. Ann Rheum Dis. 2001 Oct;60(10):913–923. doi: 10.1136/ard.60.10.913. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Stein C. M., Pincus T., Yocum D., Tugwell P., Wells G., Gluck O., Kraag G., Torley H., Tesser J., McKendry R. Combination treatment of severe rheumatoid arthritis with cyclosporine and methotrexate for forty-eight weeks: an open-label extension study. The Methotrexate-Cyclosporine Combination Study Group. Arthritis Rheum. 1997 Oct;40(10):1843–1851. doi: 10.1002/art.1780401018. [DOI] [PubMed] [Google Scholar]
  14. Twisk J. W. Different statistical models to analyze epidemiological observational longitudinal data: an example from the Amsterdam Growth and Health Study. Int J Sports Med. 1997 Jul;18 (Suppl 3):S216–S224. doi: 10.1055/s-2007-972718. [DOI] [PubMed] [Google Scholar]
  15. Weinblatt M. E., Kaplan H., Germain B. F., Block S., Solomon S. D., Merriman R. C., Wolfe F., Wall B., Anderson L., Gall E. Methotrexate in rheumatoid arthritis. A five-year prospective multicenter study. Arthritis Rheum. 1994 Oct;37(10):1492–1498. doi: 10.1002/art.1780371013. [DOI] [PubMed] [Google Scholar]
  16. Welsing P. M., van Gestel A. M., Swinkels H. L., Kiemeney L. A., van Riel P. L. The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis. Arthritis Rheum. 2001 Sep;44(9):2009–2017. doi: 10.1002/1529-0131(200109)44:9<2009::AID-ART349>3.0.CO;2-L. [DOI] [PubMed] [Google Scholar]
  17. Wolfe F. A reappraisal of HAQ disability in rheumatoid arthritis. Arthritis Rheum. 2000 Dec;43(12):2751–2761. doi: 10.1002/1529-0131(200012)43:12<2751::AID-ANR15>3.0.CO;2-6. [DOI] [PubMed] [Google Scholar]
  18. Zeger S. L., Liang K. Y. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 1986 Mar;42(1):121–130. [PubMed] [Google Scholar]
  19. van Leeuwen M. A., van Rijswijk M. H., Sluiter W. J., van Riel P. L., Kuper I. H., van de Putte L. B., Pepys M. B., Limburg P. C. Individual relationship between progression of radiological damage and the acute phase response in early rheumatoid arthritis. Towards development of a decision support system. J Rheumatol. 1997 Jan;24(1):20–27. [PubMed] [Google Scholar]
  20. van den Borne B. E., Landewé R. B., Houkes I., Schild F., van der Heyden P. C., Hazes J. M., Vandenbroucke J. P., Zwinderman A. H., Goei The H. S., Breedveld F. C. No increased risk of malignancies and mortality in cyclosporin A-treated patients with rheumatoid arthritis. Arthritis Rheum. 1998 Nov;41(11):1930–1937. doi: 10.1002/1529-0131(199811)41:11<1930::AID-ART6>3.0.CO;2-N. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES